LOS ANGELES — South African-born biotech entrepreneur Patrick Soon-Shiong has been identified as the wealthiest individual in Los Angeles, with an estimated net worth of $8.4 billion, according to wealth tracking reports.
Soon-Shiong, a surgeon and pharmaceutical innovator, built his fortune in the United States through a series of biotechnology ventures spanning cancer research, drug development, and healthcare investment. He is best known for developing Abraxane, a nanoparticle chemotherapy drug used in the treatment of breast, lung, and pancreatic cancers, which has been widely recognized as a major advancement in oncology.
Born in Port Elizabeth, South Africa, Soon-Shiong emigrated to North America, where he pursued medical research and later transitioned into entrepreneurship, founding and investing in multiple biotech companies. His business empire has since expanded into healthcare systems, artificial intelligence in medicine, and pharmaceutical manufacturing.
He also owns the Los Angeles Times, making him one of the few billionaire investors with significant influence in both healthcare and media industries.
Soon-Shiong is frequently mentioned alongside other high-profile South African-born entrepreneurs such as Elon Musk, reflecting a broader pattern of global business leaders who left South Africa and went on to build major fortunes in the United States and beyond.
Despite concerns over economic inequality and skilled migration, South Africa remains one of Africa’s leading concentrations of wealth. Reports estimate that the country accounts for approximately 34% of Africa’s millionaires, supported by its developed financial sector, mining industry, and corporate base.
However, analysts note that continued emigration of skilled professionals, particularly in medicine, engineering, and technology, continues to challenge long-term domestic innovation capacity.
Economists say the case of Soon-Shiong illustrates both the global mobility of talent and the role of international markets in shaping modern wealth creation.
